Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxaparin Dosing in Obese Post-Cesarean Patients
NCT02070237Phase 1Completed
- Sponsor
- MemorialCare
- Start
- Aug 2013
- Primary completion
- Mar 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of enoxaparin in venous thromboembolism (VTE) and pulmonary embolism (PE) (2 arms), sponsored by MemorialCare. Primary endpoint: Peak Anti-Factor Xa Level. Started Aug 2013; status: completed.
02
Drugs
enoxaparin
03
Conditions
venous thromboembolism (VTE)pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT02070237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02070237.